论文信息 - Switching from agalsidase alfa to pegunigalsidase alfa for treating Fabry disease: One year of treatment data from BRIDGE, a phase III open label study - 字舞流文

Switching from agalsidase alfa to pegunigalsidase alfa for treating Fabry disease: One year of treatment data from BRIDGE, a phase III open label study

K. Nicholls | D. Hughes | A. Linhart | G. Dostálová | P. Giraldo | E. Brill‐Almon | Sari Alon | R. Chertkoff | M. West | C. Tøndel | A. Jovanović | B. Vujkovac | Mali Szlaifer | T. Hiwot